BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pang Q, Liu C, Zhang J, Xu X. Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond the Milan criteria: A randomized controlled trial. Journal of Hepatology 2015;62:748-9. [DOI: 10.1016/j.jhep.2014.08.059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Kim H, Ahn SW, Hong SK, Yoon KC, Kim H, Choi YR, Lee HW, Yi N, Lee K, Suh K. Survival benefit of liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma. British Journal of Surgery 2017;104:1045-52. [DOI: 10.1002/bjs.10541] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
2 Solaini L, Cucchetti A, Piccino M, Gardini A, La Barba G, Serenari M, Cescon M, Ercolani G. Critical systematic review on hepatic resection and transarterial chemoembolization for hepatocellular carcinoma. Future Oncol 2019;15:439-49. [PMID: 30620230 DOI: 10.2217/fon-2018-0269] [Reference Citation Analysis]
3 Li G, Du X, Wu X, Wu S, Zhang Y, Xu J, Wang H, Chen T. Large-Scale Transcriptome Analysis Identified a Novel Cancer Driver Genes Signature for Predicting the Prognostic of Patients With Hepatocellular Carcinoma. Front Pharmacol 2021;12:638622. [PMID: 34335239 DOI: 10.3389/fphar.2021.638622] [Cited by in F6Publishing: 1] [Reference Citation Analysis]